Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwarzer Cardiotek is a leading medical technology company that specializes in the design and manufacture of sophisticated electrophysiology (EP) and hemodynamic monitoring systems. The company's flagship Evo System is widely utilized in cardiac catheterization laboratories for the diagnosis and treatment of complex arrhythmias and other cardiovascular conditions. By providing high-fidelity signal acquisition and intuitive data visualization, Schwarzer's technology assists clinicians in performing precise interventional procedures. In late 2022, the company was acquired by Circle Cardiovascular Imaging, a move aimed at combining Schwarzer's hardware excellence with Circle's market-leading cardiac imaging software. The company continues to operate as a key provider of diagnostic tools for the global cardiology market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwarzer.